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Contrasting models of promiscuous gene expression 
by thymic epithelium
 
Geoffrey O. Gillard and Andrew G. Farr
 
Medullary thymic epithelial cells (mTECs) express a broad spectrum of tissue- 
restricted self-antigens (TRAs), which are required for the development of 
central tolerance. A new study suggests that TRA expression is a specialized 
property of terminally differentiated mTECs. However, as discussed here, an 
alternative model—whereby TRA expression is regulated by conserved 
developmental programs active in developing mTECs—may be equally plausible.
 
TRAs and central tolerance
 
Multiple studies have shown that ex-
pression of TRAs by mTECs is critical
for establishing self-tolerance to these
antigens in the periphery (1). In mice
that express transgenes controlled by
peripheral tissue-specific promoters, a
scattered subset of mTECs express the
transgenic antigen, and this expression
is sufficient to tolerize the developing
T cell repertoire to the antigen. The
known mechanism of tolerance induc-
tion involves deletion of antigen-specific
thymocytes (2–4); the effect of TRA
expression on other tolerance mecha-
nisms, such as regulatory T cell devel-
opment, remains to be determined.
These studies also showed that the pat-
terns of endogenous antigen expression
in mTECs (insulin, somatostatin [2];
C-reactive protein [CRP], serum amy-
loid P component [SAP] [3]) is similar
to the expression of transgenic antigens
under the corresponding tissue-specific
promoters (RIP-Tag [2]; human CRP
[3]). This shows clearly that TRA ex-
pression by mTECs is a physiological
phenomenon that is under endogenous
transcriptional control.
Building on these early observations,
a study by Derbinski et al. (5) showed
that TRA expression by mTECs en-
compasses a large set of antigens charac-
teristic of a broad range of tissues, leading
to the formulation of the notion of
“promiscuous gene expression” as both
a phenomenon and a mechanism for
generating tolerance. When it was found
that mutations in the gene encoding the
transcriptional regulator AIRE (autoim-
mune regulator) were responsible for the
development of a multiorgan autoim-
mune  syndrome (APS-1 or APECED)
in humans, it was suggested that AIRE
might mediate TRA expression in
mTECs (for review see reference 6). In-
deed, analysis of 
 
Aire
 
 
 
/
 
 
 
 mice, which
have autoimmune activity targeted to
multiple endocrine tissues, has shown
that expression of some TRAs is reduced
or absent in 
 
Aire
 
-deficient mTECs and
that negative selection of thymocytes is
impaired (7). However, Aire cannot
account for all promiscuous gene ex-
pression, as expression of many TRAs is
unaffected in 
 
Aire
 
 
 
/
 
 
 
 mice and some of
the thymocyte selection defects ob-
served in these mice are independent of
TRA expression levels (8). The mech-
anism of Aire activity has been attrib-
uted to direct transcriptional regulation,
ubiquitin ligase activity, or unspecified
derepression of chromatin (6). How-
ever, a definitive molecular function for
Aire has not been determined yet, and
therefore, the manner in which it con-
trols thymic expression of a subset of
TRAs remains speculative.
 
mTEC differentiation: knowns 
and unknowns
 
The mechanism(s) that may account
for promiscuous gene expression by
mTECs is difficult to define because
mTECs themselves are difficult to define
(9). Regarding mTEC development, it
can be said conclusively that mTECs
are clonally derived, as shown by Ro-
dewald and colleagues (10); that de-
velopment and maintenance of the
highly heterogeneous medullary com-
partment of the thymus is dependent
on reciprocal signals between mTECs
and developing thymocytes (referred to
as cross-talk [9, 11]); and that the lym-
photoxin 
 
 
 
 receptor–NF-
 
 
 
B–inducing
kinase–relB pathway is involved in
both the induction of Aire and the
generation and/or maintenance of
mTEC heterogeneity, although whether
this pathway regulates maturation, pro-
liferation, or survival of mTECs is not
clear (12–14). The identity and rela-
tionship of mTEC subsets is also poorly
defined (9). Although some molecules
are broadly expressed by most mTECs
(such as CD80, MHC class II, Ep-Cam),
others (recognized by antibodies and
lectins such as 8.1.1, UEA-1, A2B5,
etc.) are differentially expressed by
mTEC subsets and can be used to sub-
divide the broader mTEC populations
(5, 9). There has been no demonstra-
tion of precursor/progeny relationships
among the various mTEC subsets, and
thus the maturation state, developmen-
tal potential, and homogeneity of these
subsets is undetermined and open to
speculation.
 
Refining the promiscuous gene 
expression model
 
In this issue, Derbinski et al. (see page
33) provide important clues to the
regulation of TRA expression by
mTECs (15). They describe a hierar-
chy of TRA expression by subsets of
mTECs that are defined by levels of
expression of the costimulatory molecule
CD80, with the level of CD80 expres-
sion increasing as a function of mTEC
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maturity. This correlation was noted
in both 
 
Aire
 
-deficient and wild-type
mTECs, emphasizing that Aire-inde-
pendent mechanisms play an important
role in regulating TRA expression.
The results pertaining to the role of
Aire in this process will be addressed in
more detail later. They also provide ev-
idence that some of the genes encoding
TRAs expressed by the CD80
 
hi
 
 mTEC
population are clustered together on
chromosomes, suggesting potential
epigenetic regulation of this process.
Whereas expression of TRAs in pe-
ripheral tissues is regulated by tissue-
specific transcription factors, the au-
thors propose that mature mTECs
open regions of chromatin and express
the clusters of genes in these open re-
gions (Fig. 1 A). Based on their new
data, the authors propose a modified
version of the promiscuous gene ex-
pression model—termed the “terminal
differentiation” model—in which pro-
miscuous gene expression by mTECs is
a specialized property that is attained
upon terminal differentiation.
This model is cogent and provides a
reasonable explanation for their obser-
vations. However, because of the large
gaps in our understanding of thymic ep-
ithelial differentiation, the model pro-
posed by Derbinski et al. is based on a
number of assumptions (15). We wish
to point out that these data can be in-
terpreted differently when alternative
but equally valid assumptions are made
regarding thymic epithelial differentia-
tion. For instance, by attributing TRA
expression to mature mTECs this
model implies that thymic epithelial
progenitor cells have a restricted tran-
scriptional profile and would express
mTEC-specific molecules before acti-
vation of TRA expression. At this time,
we are not aware of many genes, struc-
tural or regulatory, that can be used to
define a unique thymic epithelial “iden-
tity,” nor is there evidence that these
progenitor cells are committed to the
mTEC lineage. As will be discussed in
An alternative to… section, there are
grounds to consider the potential of ep-
ithelial progenitor cells or immature
thymic epithelial cells to express TRAs.
Some have assumed that the pro-
gram of mTEC differentiation resem-
bles that of dendritic cells, where high
levels of CD80, CD86, and MHC class
II expression are considered to be
markers of maturation. However, sev-
eral observations suggest that expres-
sion of these molecules by nonhemato-
poietic cells may be inducible and not
constitutive, and independent of matu-
ration state (16, 17). For example,
mTECs and mTEC cell lines can be
induced to express MHC class II at
high levels by exposure to IFN-
 
 
 
 (18).
In mice lacking promoter IV (pIV) of
the class II transactivator (CIITA),
hematopoietic antigen-presenting cells
constitutively express MHC class II,
whereas nonhematopoietic cells do not
express MHC class II constitutively
(cortical thymic epithelial cells) or in
response to systemic IFN-
 
 
 
 treatment
Figure 1. Models of the mechanisms resulting in TRA expression by mTECs. (A) The terminal 
differentiation model. As a committed mTEC progenitor (p) cell differentiates, it progressively expresses 
an increasing number of TRAs, starting at an immature (im) stage and culminating in a terminally 
differentiated (mature [m]) cell that is characterized by high level expression of MHC class II, CD80, 
Aire, and a broad spectrum of TRAs (represented by colored circles). The role of Aire in this model is 
undefined but is progressively manifested during mTEC maturation. (B) The developmental model. 
Progenitors have access to a wide variety of lineage-specific transcriptional programs (and the TRAs 
regulated by those programs) before differentiation. As part of the differentiation process, some of 
the transcriptional networks are silenced as individual cells mature. Each of these mature cells might 
express a peripheral lineage program (i and iii), or might extinguish all peripheral regulators and 
express an undefined terminal mTEC program (ii). In the developmental model, MHC class II and co-
stimulatory molecules like CD80 would be inducibly expressed on mTECs throughout differentiation 
in response to cell–cell or other extrinsic signals. We speculate that Aire acts at early stages of mTEC 
differentiation, perhaps by regulating lineage decisions or by controlling temporal patterns of the 
differentiation process.
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(multiple cell types; reference 17).
Therefore, the CD80
 
hi
 
 subset of mTEC
may reflect a state of epithelial activa-
tion in response to local stimuli rather
than a subset of thymic epithelial cells
at a particular stage of maturation.
Derbinski et al. further assume that the
CD80
 
hi
 
 subset of mTECs represents a
homogenous and mature population,
even though several molecules charac-
teristic of embryonic stem cells (Dppa3,
Utf-1) and stem cell populations (SCA-1)
as well as early regulators of endoder-
mal tissue development (Cdx1, Foxa1)
are enriched in this “mature” CD80
 
hi
 
mTEC population (15).
 
An alternative to the “terminal 
differentiation” model
 
We suggest an alternative interpreta-
tion of the data presented in the study
by Derbinski et al. (15) that is based on
several different underlying assump-
tions regarding the development and
character of the medullary thymic epi-
thelium. We propose that conserved
developmental mechanisms regulate
TRA expression by mTECs, possibly
in one or several ways. First, the ab-
sence of a well-defined population of
thymic epithelial progenitor cells or
well-defined markers that are unique
for thymic epithelium suggests that the
earliest thymic epithelial progenitor
cells could be multipotent and not ini-
tially restricted to a thymic lineage. Ac-
cording to this scenario, multiple con-
served transcriptional programs that
reflect the multipotential nature of
these progenitor cells would result in
the display of a broad spectrum of
TRAs (Fig. 1 B). As cells differentiate
(defined here as a progressive restric-
tion of developmental potential or
a narrowing of developmental fate
choices), there would be sequential si-
lencing or inactivation of some of these
transcriptional programs, leading to ter-
minally differentiated cells. Although
the duration of the expression profile
for peripheral transcriptional networks
may vary, the products specified by
these networks would contribute to the
set of tissue-restricted structural and
regulatory genes that are expressed by
mTECs. This process might increas-
ingly restrict the expression of discrete
sets of tissue-restricted genes as the cells
develop (19–21), and allow individual
cells to terminally differentiate into ei-
ther a peripheral lineage fate (2, 22)
(Fig. 1 B, i and iii) or lead to the silenc-
ing of peripheral transcription net-
works after commitment to a termi-
nal—as yet undefined—mTEC fate
(depicted in Fig. 1 B, ii). We suggest
that expression of these peripheral tran-
scriptional programs in various individ-
ual cells might account for the molecu-
lar mosaic of peripheral self-antigens
that are represented within medullary
thymic epithelium. If progressive si-
lencing of gene expression is associated
with differentiation, individual imma-
ture mTECs should express a wider ar-
ray of TRAs than mature mTECs, re-
gardless of the terminal fate of the
mature cell. In addition, the mecha-
nisms that regulate expression of spe-
cific TRAs by mTECs should be simi-
lar to those active in native tissues. The
terminal differentiation model pro-
posed by Derbinski and colleagues pre-
dicts the opposite, with terminally
differentiated mTEC expressing the
highest levels of TRAs as a result of
epigenetic derepression or other regu-
latory mechanisms that are not recapit-
ulated in the periphery (15).
 
Arguments in favor of 
progressive restriction
 
Although the progressive restriction of
transcriptional programs as a mecha-
nism of differentiation has received lit-
tle attention in epithelial cells, such
mechanisms have been described in he-
matopoietic cells. Studies using either
isolated early hematopoietic progeni-
tors (19, 23) or more mature he-
matopoietic cells (24) have shown that
immature cells can express genes
characteristic of lineages that are dis-
tinct from their terminally differenti-
ated fates. For example, pro–B cells de-
ficient in the transcription factor Pax5,
which are incapable of commitment to
the B cell lineage, can differentiate into
mature T cells (24). By examining lin-
eage-specific gene expression patterns
in early hematopoietic populations,
Miyamoto et al. (23) concluded that
multiple lineage-affiliated differentia-
tion programs are activated at the tran-
scriptional level before commitment.
In this context, what has been de-
scribed in the past as promiscuity of
gene expression or lineage commit-
ment could simply reflect the ability of
immature cells to utilize multiple de-
velopmental programs. This interpreta-
tion differs significantly from the
promiscuous gene expression of the
terminal differentiation model, whereby
genes are expressed nonspecifically as
long as their chromosomal “neighbor-
hood” is accessible.
The components necessary for a
developmental, progressive restriction
model are all present in the thymus: a
cycling population of epithelial cells
(1) in an environment replete with the
mechanisms and signaling pathways
that are involved in the development
of peripheral epithelial (and non-
epithelial) tissues. These include the
Notch, Hedgehog, bone morphogenic
protein (BMP), fibroblast growth
factor (FGF), and Wnt signaling path-
ways (9). A recent study demonstrated
that transplanted fetal pharyngeal
pouch endoderm can generate thymus
and other endodermally derived struc-
tures, such as pharyngeal and gut tis-
sues, and that transplanted embryonic
day 9 fetal pharyngeal arches (which
normally give rise to the thymus) can
generate a wide range of tissue types,
including skin, hair, cartilage, bone,
muscle, and adipose tissue (25). There-
fore, it seems reasonable that the ability
of mTECs to express a remarkably
wide range of TRAs may reflect a gen-
eral developmental process that occurs
in a tissue with high levels of cellular
turnover, broad developmental poten-
tial, and complex environmental cues
that can direct individual mTEC pre-
cursors into various developmental
pathways. Although the plasticity of
the medullary compartment has been
shown in multiple experimental con-
texts (9), the identity and differentia-
tion potential of mTEC progenitors
remains to be determined.
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The TRA expression data (3, 4, 5,
26) and chromosomal clustering analy-
ses presented in previous studies (27)
are consistent with either model. The
clustered pattern of TRA expression
noted by Derbinski et al. (15) was in-
terpreted to reflect derepressed loci in a
homogeneous, terminally differentiated
epithelial population that is capable of
promiscuous gene expression. But this
clustering could also result from imma-
ture populations of precursor cells that
have retained a broad transcriptional
profile, or could represent the summed
expression by a heterogeneous mixture
of cells, each of which expresses a spe-
cific set of peripheral lineage genes.
The same can be said for the data
showing biallelic expression of the in-
sulin-like growth factor 2 (
 
Igf2
 
) gene
by mTECs, which Derbinski et al. pro-
pose as evidence for a loss of normal
gene imprinting (15). This biallelic ex-
pression pattern might instead reflect a
lack of imprinting in immature progen-
itors, or a heterogeneous mixture of
cells that individually express 
 
Igf2
 
 either
mono- or biallelically in a develop-
mental or lineage-specific manner (28).
 
The role of Aire in regulating 
TRA expression
 
The data presented in the current study
indicate that Aire does not regulate
TRA expression by random derepres-
sion of loci or chromatin remodeling
mechanisms as previously proposed (1,
5, 27, 29). For example, within the
casein locus the authors show that
casein 
 
 
 
 is not expressed by CD80
 
hi
 
Aire
 
 
 
/
 
 
 
 mTECs. However, this cannot
be attributed to a locus that is “closed”
by the absence of Aire, as the ability of
CD80
 
hi
 
 
 
Aire
 
 
 
/
 
 
 
 mTECs to express the
casein 
 
 
 
 and 
 
 
 
 genes (which flank
casein 
 
 
 
; reference 30) demonstrates
that the locus must be open in some
cells. Therefore, the mechanism by
which Aire affects casein 
 
 
 
 expression
appears to be independent of wholesale
chromatin remodeling, run-on tran-
scription of open loci, or direct tran-
scriptional regulation of specific genes.
By extension, that Aire is required
for casein 
 
 
 
 expression in wild-type
mTECs (which have an accessible lo-
cus) suggests that for both Aire-depen-
dent and Aire-independent antigens
epigenetic mechanisms alone are not
sufficient for TRA expression.
 
Outstanding questions
 
The data and model put forth by
Derbinski et al. highlight the complex
and ill-defined nature of mTEC differ-
entiation and advocate an intriguing
model to account for the observed
TRA expression (15). However, it re-
mains to be determined whether TRA
expression reflects a novel derepression
mechanism that is unique to mTECs, as
they have proposed, or whether it
results from developmentally conserved
mechanisms that are active in a permis-
sive environment. In either case, the
results presented delineate important
functional parameters of this phenome-
non and help define key issues that need
to be resolved before the mechanisms
underlying TRA expression can be un-
derstood. These include the identity,
developmental potential, and plasticity
of resident mTEC progenitors, the pre-
cursor–progeny relationships between
the various subsets of mTECs, and the
means to isolate defined, homogeneous
subsets of mTECs to test these models
directly. It seems likely that the mecha-
nisms controlling thymic epithelial cell
differentiation and those that control
the expression of TRAs will be found
to be highly convergent.
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